GeneIII is headquartered in Nanjing. It is a synthetic biology technology company that integrates research and development, production, and sales. In just two years since its establishment, GeneIII has rapidly achieved the industrial-scale production of ergothioneine. Leveraging a cGMP pharmaceutical-grade production platform, the company efficiently produces EGT with a purity of 99.97%, establishing a significant advantage in terms of quality, production capacity, and cost in the EGT market.